SCIENTIFIC BACKGROUND

APOC2

 

SCIENTIFIC BACKGROUND

Due to its central role in the activation of lipoprotein lipase (Lpl), apolipoprotein C-II (Apo C-II) plays an important role in the metabolism of triglyceride-rich lipoproteins, especially chylomicrons. Primary Apo C-II deficiency is a rare autosomal recessive inherited metabolic defect characterized by extremely elevated serum concentrations of triglycerides (up to 30,000 mg/dl) and chylomicrons (milky creamy serum, Fredrickson's hyperlipidemia type I). In addition to the hereditary form, an acquired, reversible form of apo C-II deficiency has also been described, which can be caused, for example, by chemotherapy. The diagnosis is mostly made in the context of recurrent pancreatitis (DD: hereditary pancreatitis); eruptive xanthomas and hepatomegaly are common phenotypic features that occur only in the congenital form. Apo C-II deficiency is not associated with increased coronary risk. Treatment consists of a low-fat diet, alcohol abstinence, and administration of fibrates when appropriate. Fibrates induce the expression of Lpl through activation of the transcription factor PPARalpha, which can further lower serum triglyceride concentrations. Therefore, fibrate therapy is only beneficial if the LPL gene is intact. Because LPL deficiency is also associated with type I hyperlipidemia, molecular genetic analysis of the LPL gene may be useful in the context of treatment planning.

 

The disease is caused by homozygous or mixed heterozygous pathogenic variants in the APOC2 gene that secondarily lead to functional Lpl deficiency. The APOC2 gene is located on chromosome 19 and is localized in the APOE/APOC1/APOC2 gene cluster.

 

References

Wolska et al. 2017, Atherosclerosis 267:49 / Mendoza-Barberá et al. 2013, J Lipid Res 54:649 / Brahm et Hegele 2013, Nutrients 5:981 / Burnett et al. 2017, GeneReviews® [Internet]

GENES

APOC2

ASSOCIATED TESTS

How to order

LATEST ARTICLES

Cancer is a group of genetic diseases that can develop almost anywhere in the body. Many people in the world are affected by cancer every year. Follo...

Read more

Aiming to evaluate the role of chromosomal aneuploidy in pregnancy loss, a 2023 study 35 years in the making evaluated the genomic landscape of first...

Read more

Cancer is a complex genetic disease that affects millions of people in the world. It is one of the leading causes of death worldwide, with about ten ...

Read more

Researchers created a detailed map of the placenta during labor. By studying how maternal and fetal cells communicate, they discovered signals in the...

Read more

A recent paper published in Nature Medicine (1) aimed to identify genes and genomic biomarkers which can better predict outcomes and personalized the...

Read more

In honor of the international day of women and girls in science, we interviewed one of our very own, Dr. Evelina Papaioannou. Dr. Evelina Pa...

Read more

Aneuploidies, such as translocations, whole or segmental chromosomal duplications, and deletions, are examples of chromosomal abnormalities that are ...

Read more

Here you can read the winning essays from the first, annual DNA essay competition on the subject of "How unfolding the DNA code can help with precisi...

Read more

Introduction Our voices are as unique as our fingerprints! Although there are people whose voices might sound alike, there are no two voices exact...

Read more

Not everyone likes winter. For people who do not enjoy the cold weather, or having to put on a thick coat to go outside, a winter can be a source of ...

Read more